Indication

Hypermagnesemia

Hypermagnesemia is an electrolyte disturbance defined by abnormally elevated serum magnesium concentrations, typically exceeding 2.6 mg/dL (1.1 mmol/L or 2.2 mEq/L). Read more about Hypermagnesemia

37 drugs 26 manufacturers

Drugs that treat it

Common Hypermagnesemia therapies.

Showing 37–37 of 37 drugs

Sort

CALCIUM GLUCONATE

CALCIUM·HYPERMAGNESEMIA·+5

GLENMARK PHARMA

Filter & compare in the drug finder →Opens the drug finder with Hypermagnesemia preselected.

News & literature

Coming soon

Related codes

Coming soon

About Hypermagnesemia.

Hypermagnesemia is an electrolyte disturbance defined by abnormally elevated serum magnesium concentrations, typically exceeding 2.6 mg/dL (1.1 mmol/L or 2.2 mEq/L).

Primarily affecting the neuromuscular and cardiovascular systems, it most commonly arises in patients with acute or chronic renal impairment who cannot sufficiently excrete magnesium, or in hospital settings following excessive administration of magnesium-containing antacids, laxatives, or intravenous therapies.

Pathophysiologically, excess magnesium acts as a physiological calcium channel blocker and impedes acetylcholine release at the neuromuscular junction, leading to dose-dependent clinical manifestations.

Mild elevations often present with flushing, nausea, and hyporeflexia, whereas severe hypermagnesemia can precipitate flaccid paralysis, respiratory depression, bradycardia, severe hypotension, heart block, and fatal cardiac arrest.

nih.gov
Hypermagnesemia is an electrolyte disturbance defined by abnormally elevated serum magnesium concentrations, typically exceeding 2.6 mg/dL (1.1 mmol/L or 2.2 mEq/L) Primarily affecting the neuromuscular and cardiovascular systems, it most commonly arises in patients with acute or chronic renal impairment who cannot sufficiently excrete magnesium, or in hospital settings following excessive administration of magnesium-containing antacids, laxatives, or intravenous therapies
nih.gov
Primarily affecting the neuromuscular and cardiovascular systems, it most commonly arises in patients with acute or chronic renal impairment who cannot sufficiently excrete magnesium, or in hospital settings following excessive administration of magnesium-containing antacids, laxatives, or intravenous therapies
nih.gov
Primarily affecting the neuromuscular and cardiovascular systems, it most commonly arises in patients with acute or chronic renal impairment who cannot sufficiently excrete magnesium, or in hospital settings following excessive administration of magnesium-containing antacids, laxatives, or intravenous therapies
nih.gov
Pathophysiologically, excess magnesium acts as a physiological calcium channel blocker and impedes acetylcholine release at the neuromuscular junction, leading to dose-dependent clinical manifestations
nih.gov
Mild elevations often present with flushing, nausea, and hyporeflexia, whereas severe hypermagnesemia can precipitate flaccid paralysis, respiratory depression, bradycardia, severe hypotension, heart block, and fatal cardiac arrest
nih.gov
Mild elevations often present with flushing, nausea, and hyporeflexia, whereas severe hypermagnesemia can precipitate flaccid paralysis, respiratory depression, bradycardia, severe hypotension, heart block, and fatal cardiac arrest
nih.gov
Mild elevations often present with flushing, nausea, and hyporeflexia, whereas severe hypermagnesemia can precipitate flaccid paralysis, respiratory depression, bradycardia, severe hypotension, heart block, and fatal cardiac arrest

Personalize your experience

Follow Hypermagnesemia and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it